M
MiNA Therapeutics
0 followers
Harnessing an innate mechanism of gene activation, MiNA Therapeutics' platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases.
Org chart
Robert Habib Mba
Collapse
Troels Koch
CTO
Robin Wright
Group Chief Financial Officer
Peter Bains
Chief Business Officer
Bríd Ryan
SVP, Research
Board & advisors
Robert Lechler
Chairman
Gur Roshwalb
Non Executive Director
Robert C. Kopple
Non Executive Director
Antonin de Fougerolles
Scientific Advisor
Hans Huber
Scientific Advisor
Susan Clement Davies
Director
Pål Sætrom
Co-Founder & Scientific Advisor
John Rossi
Co-Founder & Scientific Advisor
Declan Doogan
Scientific Advisor
Deya Corzo
Scientific Advisor
Nagy Habib
Scientific Advisor